|
Sign In to gain access to subscriptions and/or personal tools.
|
Review: Vascular calcification in chronic kidney disease: the tip of the chalk-berg
Stephan Brincat
Department of Nephrology and Transplantation, Guy's Hospital, London, UK
David Ja Goldsmith
Department of Nephrology and Transplantation, Guy's Hospital, London, UK, david.goldsmith{at}gstt.nhs.uk
The most common cause of death in dialysis patients is cardiovascular disease. As yet, no convincing evidence of useful therapeutic interventions exists. This huge increase in cardiovascular mortality may be due in part to the presence of excess vascular calcification, particularly in the form of extensive coronary artery calcification, which can be observed even in very young dialysis patients. The reasons for this very widespread problem are in fact complicated and numerous, with an interaction between patient characteristics, external changes, such as mineral and bone metabolism parameters, and other less well characterised influences. The use of sevelamer rather than significant doses of calcium as the primary oral phosphate binder seems to be associated with a reduction in the development and progression of vascular calcification, at least in some studies. Br J Diabetes Vasc Dis, 2008; 8: 264—269
Key Words: calcification calcium phosphate
References
- Covic A., Gusbeth-Tatomir P., Goldsmith D. Negative outcome studies in end-stage renal disease: how dark are the storm clouds? Nephrol Dial Transplant 2008; 23:56-61.[Free Full Text]
- Shroff RC, Shah V., Hiorns MP et al. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 2008 May 9 [Epub ahead of print].
- Goldsmith D., Ritz E., Covic A. Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? Kidney Int 2004; 66:1315-33.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bellasi A., Raggi P. Techniques and technologies to assess vascular calcification. Semin Dial 2007; 20:129-33.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kramer H., Toto R., Peshock R. et al. Association between chronic kidney disease and coronary artery calcification: The Dallas Heart Study. J Am Soc Nephrol 2005; 16:507-13.[Abstract/Free Full Text]
- Tomiyama C., Higa A., Dalboni MA et al. The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients. Nephrol Dial Transplant 2006; 21:2464-71.[Abstract/Free Full Text]
- Russo D., Palmiero G., De Blasio AP et al. Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 2004; 44:1024-30.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15:2208-18.[Abstract/Free Full Text]
- Haydar AA, Covic A., Colhoun H. et al. Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int 2004; 65:1790-4.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- London GM, Guérin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18:1731-40.[Abstract/Free Full Text]
- Haydar AA, Hujairi NM, Covic AA et al. Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: A study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant 2004; 19:2307-12.[Abstract/Free Full Text]
- Matsuoka M., Iseki K., Tamashiro M. et al. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004; 8:54-8.[CrossRef][Medline]
[Order article via Infotrieve]
- Sigrist MK, Taal MW, Bungay P., McIntyre CW Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2007; 2:1241-8.[Abstract/Free Full Text]
- Chertow GM, Burke SK, Raggi P. Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62:245-52.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Block GA, Spiegel DM, Ehrlich J. et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005; 68:1815-24.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Block GA, Raggi P., Bellasi A. et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007; 71:438-41.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Silver J. The details bedevil DCOR. Kidney Int 2007; 72:1041-3.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Qunibi W., Moustafa M., Muenz LR et al. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis 2008; 51(6):952-65.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Moe SM, O'Neill KD, Resterova M. et al. Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant 2004; 19:2387-93.[Abstract/Free Full Text]
- Oschatz E., Benesch T., Kodras K. et al. Changes of coronary calcification after kidney transplantation. Am J Kidney Dis 2006; 48:307-13.[CrossRef][Medline]
[Order article via Infotrieve]
- Schankel, K., Robinson J., Bloom R. et al. Determinants of coronary artery calcification progression in renal transplant recipients. Am J Transplant 2007; 7:2158-64.[CrossRef][Medline]
[Order article via Infotrieve]
- Rosenblum IY, Black HE, Ferrell JF The effects of various diphosphonates on a rat model of cardiac calciphylaxis. Calcif Tissue Res 1977; 23:151-9.[CrossRef][Medline]
[Order article via Infotrieve]
- Nitta K., Akiba T., Suzuki K. et al. Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis 2004; 44:680-8.[CrossRef][Medline]
[Order article via Infotrieve]
- Hashiba H., Aizawa S., Tamura K. et al. Inhibitory effects of etidronate on the progression of vascular calcification in hemodialysis patients. Ther Apher Dial 2004; 8:241-7.[CrossRef][Medline]
[Order article via Infotrieve]
- Fleckenstein-Grün G., Thimm F., Frey M., Matyas S. Progression and regression by verapamil of vitamin D3-induced calcific medial degeneration in coronary arteries of rats. J Cardiovasc Pharmacol 1995; 26:207-13.[Medline]
[Order article via Infotrieve]
- Bleyer AJ, Burkart J., Piazza M. et al. Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD. Am J Kidney Dis 2005; 46:464-9.[Medline]
[Order article via Infotrieve]
The British Journal of Diabetes & Vascular Disease, Vol. 8, No. 6,
264-271 (2008)
DOI: 10.1177/1474651408096679

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|